Title: Case Presentation
1(No Transcript)
2(No Transcript)
3Case Presentation
4Discussion of Question 1
5Discussion of Question 2
6Case Presentation (cont)
7Discussion of Question 3
8Focus on Nausea Current Trends in Patient
Assessment and Treatment Approaches
9Proposed Pathways of Chemotherapy-Induced Emesis
10Emetic Risk Categories
11Risk Factors for Chemotherapy-Induced Nausea and
Vomiting
12Classification of Chemotherapy-Induced Nausea and
Vomiting
13Delayed Emesis
14Treatment Algorithm Control of
Chemotherapy-Induced Emesis
15Serotonin Antagonists and Dosage
16Off-Label Agents for the Control of
Chemotherapy-Induced Nausea
17Gabapentin for the Control of CINV Study Design
18(No Transcript)
19(No Transcript)
20Gabapentin Control of CINV
21Olanzapine Palonosetron Dexamethasone vs
Aprepitant Palonosetron Dexamethasone Study
Design
22(No Transcript)
23(No Transcript)
24Olanzapine as an Antiemetic
25Case Presentation (cont)
26Discussion of Question 4
27Case Presentation (cont)
28Discussion of Question 5
29Discussion of Question 6
30Discussion of Question 7
31Discussion of Question 8
32CINV Links to Anorexia/Cachexia
33(No Transcript)
34Questions to Consider
35Emetic Reflex Arc and Anorexia Similar Pathways
36Anorexia Seems to Improve With Effective
Chemotherapy
37Adjuvant chemotherapy is linked to weight gain.
38Caloric Intake is Not Necessarily
Reduced/Increased With Adjuvant Chemotherapy vs
Localized Treatment
39Point 1 Main Concepts
40Questions to Consider
41Multiple, placebo-controlled clinical trials
suggest the following
42Palliating Anorexia in Cancer Patients
43Megestrol Acetate Appears to Also Help With
Vomiting (This Shouldnt Be Surprising)
44Point 2 Main Concepts
45Recognizing the Importance of Cachexia in Cancer
46(No Transcript)
47(No Transcript)
48(No Transcript)
49(No Transcript)
50(No Transcript)
51(No Transcript)
52(No Transcript)
53(No Transcript)
54(No Transcript)
55(No Transcript)
56(No Transcript)
57(No Transcript)
58Thank you for participatingin this activity.